![Francisco Armero Gutiérrez](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Francisco Armero Gutiérrez
Private Equity Investor bei Clave Mayor SGEIC SA
Aktive Positionen von Francisco Armero Gutiérrez
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Clave Mayor SGEIC SA
![]() Clave Mayor SGEIC SA Investment ManagersFinance Clave Mayor SGEIC SA (Clave Mayor) is an independent private equity firm founded in 2002. The firm is headquartered in Pamplona with additional offices in Valencia, Spain. | Private Equity Investor | 01.05.2012 | - |
Karriereverlauf von Francisco Armero Gutiérrez
Ehemalige bekannte Positionen von Francisco Armero Gutiérrez
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
HepaCyl Therapeutics SL
![]() HepaCyl Therapeutics SL BiotechnologyHealth Technology HepaCyl Therapeutics SL is a holding company engaged in the design and development of biomedical products for the detection and treatment of hepatitis and cancer. The company was founded on March 5, 2010 and is headquartered in Valladolid, Spain. | Direktor/Vorstandsmitglied | - | 01.02.2016 |
Traslational Cancer Drugs Pharma SL
![]() Traslational Cancer Drugs Pharma SL BiotechnologyHealth Technology Traslational Cancer Drugs Pharma SL engages in the discovery and development of therapeutic solutions for the treatment of cancer. Its TCD-717 choline kinase alpha inhibitor is an intravenously-administered small molecule designed to target cancer cells. It also provides technology in-licensing and out-licensing services. The company was founded by Juan Carlos San Juan on July 29, 2005 and is headquartered in Valladolid, Spain. | Direktor/Vorstandsmitglied | - | - |
Mevion Technology SL
![]() Mevion Technology SL Miscellaneous Commercial ServicesCommercial Services Mevion Technology SL is a holding company engaged in the provision of industrial ionization services, using electron beam accelerators. This technology finds applications in the medical, pharmaceutical, electronics, and aerospace sectors, and allows for product sterilization, sanitation, crosslinking, and depolymerization. It also provides technical consulting, logistics, and microbiological analysis services. The company was founded on September 11, 2009 and is headquartered in Olvega, Spain. | Direktor/Vorstandsmitglied | - | - |
Ausbildung von Francisco Armero Gutiérrez
University of Valladolid | Undergraduate Degree |
Instituto de Empresa SL | Graduate Degree |
Universida de Alcalá de Henares | Graduate Degree |
Statistik
International
Spanien | 8 |
Operativ
Director/Board Member | 3 |
Graduate Degree | 2 |
Private Equity Investor | 1 |
Sektoral
Consumer Services | 4 |
Health Technology | 3 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
Clave Mayor SGEIC SA
![]() Clave Mayor SGEIC SA Investment ManagersFinance Clave Mayor SGEIC SA (Clave Mayor) is an independent private equity firm founded in 2002. The firm is headquartered in Pamplona with additional offices in Valencia, Spain. | Finance |
HepaCyl Therapeutics SL
![]() HepaCyl Therapeutics SL BiotechnologyHealth Technology HepaCyl Therapeutics SL is a holding company engaged in the design and development of biomedical products for the detection and treatment of hepatitis and cancer. The company was founded on March 5, 2010 and is headquartered in Valladolid, Spain. | Health Technology |
Mevion Technology SL
![]() Mevion Technology SL Miscellaneous Commercial ServicesCommercial Services Mevion Technology SL is a holding company engaged in the provision of industrial ionization services, using electron beam accelerators. This technology finds applications in the medical, pharmaceutical, electronics, and aerospace sectors, and allows for product sterilization, sanitation, crosslinking, and depolymerization. It also provides technical consulting, logistics, and microbiological analysis services. The company was founded on September 11, 2009 and is headquartered in Olvega, Spain. | Commercial Services |
Traslational Cancer Drugs Pharma SL
![]() Traslational Cancer Drugs Pharma SL BiotechnologyHealth Technology Traslational Cancer Drugs Pharma SL engages in the discovery and development of therapeutic solutions for the treatment of cancer. Its TCD-717 choline kinase alpha inhibitor is an intravenously-administered small molecule designed to target cancer cells. It also provides technology in-licensing and out-licensing services. The company was founded by Juan Carlos San Juan on July 29, 2005 and is headquartered in Valladolid, Spain. | Health Technology |